Abstract
This study aimed to determine understanding the role of serum copper, zinc and copper/zinc ratio with tumor staging in people newly diagnosed to be affected with Head and Neck cancer and by comparing with age matched health individuals devoid of any orodental maladies. The study included patients confirmed to be affected with HN cancer with histological diagnosis of Head and Neck cancer (60) and age matched healthy volunteers (N = 23). The demographic details like age, domicile, menopausal status and pathological details (like tumor stage, number of lymph node involvement, tumor size) were collected from the patient's hospital data file. The serum levels of zinc and copper assayed as per standard procedures and the zinc/copper was calculated for the cancer patients and controls. The data were subjected to unpaired “t” test and ANOVA with Bonferroni’s multiple comparisons. The association between zinc and copper levels with pathological details between the variables was ascertained using the Pearson correlation coefficient(r). A statistical value of p < 0.05 was considered to be significant in agreeance to the accepted norms. Results: This result of the study indicates that when compared to the healthy individuals, the serum levels of copper, and zinc, and copper/zinc ratio were high in patients with H&N cancer. Also when compared with controls, the levels of zinc decreased, while that of copper and copper/zinc ratio increased in people affected with H&N cancer (p = 0.017 to 0.0001) and with the stage of the tumor (p = 0.03 to 0.001). The results of the study suggest that levels of serum zinc were significantly lower and that of copper higher in H&N cancer patients than that in controls and also that it was dependent on the tumor stage. When analyzed cumulatively the results hint that zinc and copper, due to their role in free radical generation and prevention have an important role in cancer progression and possible prevention by judicious intervention.
Similar content being viewed by others
Reference:s
Mattiuzzi C, Lippi G (2020) Cancer statistics: a comparison between world health organization (WHO) and global burden of disease (GBD). Eur J Public Health 30(5):1026–1027
McGuire S. (2016) World Cancer Report (2014) Geneva, Switzerland: world health organization, international agency for research on cancer, WHO Press, 2015. Adv Nutr. 7(2):418–419. https://doi.org/10.1038/s41571-019-0227-z
Cramer JD, Burtness B, Le QT, Ferris RL (2019) The changing therapeutic landscape of head and neck cancer. Nat Rev Clin Oncol 16(11):669–683
Auperin A (2020) Epidemiology of head and neck cancers: an update. Curr Opin Oncol 32(3):178–186
Kang H, Kiess A, Chung CH (2015) Emerging biomarkers in head and neck cancer in the era of genomics. Nat Rev Clin Oncol 12(1):11–26
Prabhash K, Babu G, Chaturvedi P, Kuriakose M, Birur P, Anand AK et al (2020) Indian clinical practice consensus guidelines for the management of squamous cell carcinoma of head and neck. Indian J Cancer 57(Supplement):S1–S5
Shah SB, Sharma S, D’Cruz AK (2016) Head and neck oncology: the indian scenario. South Asian J Cancer 5(3):104–105
Sarode G, Maniyar N, Sarode SC, Jafer M, Patil S, Awan KH (2020) Epidemiologic aspects of oral cancer. Dis Mon 66(12):100988
Patil VM, Noronha V, Joshi A, Agarwal J, Ghosh-Laskar S, Budrukkar A et al (2019) A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer. Cancer 125(18):3184–3197
Kocarnik J (2020) Cancer’s global epidemiological transition and growth. Lancet 395(10226):757–758
Jethwa AR, Khariwala SS (2017) Tobacco-related carcinogenesis in head and neck cancer. Cancer Metastasis Rev 36(3):411–423
Dhull AK, Atri R, Dhankhar R, Chauhan AK, Kaushal V (2018) Major risk factors in head and neck cancer: a retrospective analysis of 12-year experiences. World J Oncol 9(3):80–84
Kirtonia A, Sethi G, Garg M (2020) The multifaceted role of reactive oxygen species in tumorigenesis. Cell Mol Life Sci 77(22):4459–4483
Snezhkina AV, Kudryavtseva AV, Kardymon OL, Savvateeva MV, Melnikova NV, Krasnov GS et al (2019) ROS generation and antioxidant defense systems in normal and malignant cells. Oxid Med Cell Longev 2019:6175804
Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160(1):1–40
Askari A, Long CL, Blakemore WS (1980) Zinc, copper, and parenteral nutrition in cancer A review. JPEN J Parenter Enteral Nutr. 4(6):561–571. https://doi.org/10.1177/0148607180004006561
Chen F, Wang J, Chen J, Yan L, Hu Z, Wu J et al (2019) Serum copper and zinc levels and the risk of oral cancer: a new insight based on large-scale case-control study. Oral Dis 25(1):80–86
Weismann K. Zinc metabolism. (2004) In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook’s textbook of dermatology. Seventh ed: Wiley-Blackwell. (p. 57–100)
Hojyo S, Fukada T (2016) Roles of Zinc Signaling in the Immune System. J Immunol Res 2016:6762343
Prasad AS (1983) Zinc deficiency in human subjects. Prog Clin Biol Res 129:1–33
Ertekin MV, Tekin SB, Erdogan F, Karslioglu I, Gepdiremen A, Sezen O et al (2004) The effect of zinc sulphate in the prevention of radiation-induced dermatitis. J Radiat Res 45(4):543–548
Gupta M, Mahajan VK, Mehta KS, Chauhan PS (2014) Zinc therapy in dermatology: a review. Dermatol Res Pract 2014:709152
Shuai T, Yi LJ, Tian X, Chen WQ, Chen H, Li XE (2018) Prophylaxis with oral zinc sulfate against radiation-induced oropharyngeal mucositis in patients with head and neck cancer: protocol for a meta-analysis of randomized controlled trials. Medicine (Baltimore) 97(48):e13310
Bhaskaran P, K. K. (1996) Trace elements of clinical significance–zinc and selenium. In: Bamji MS, Rao NP, Reddy V (eds) Textbook of human nutrition. Oxford and IBH Publishing, New Delhi, India, pp 314–320
Garber K (2015) Cancer’s copper connections. Science 349(6244):129
Baharvand M, Manifar S, Akkafan R, Mortazavi H, Sabour S (2014) Serum levels of ferritin, copper, and zinc in patients with oral cancer. Biomed J 37(5):331–336
Paul RR, Chatterjee J, Das AK, Cervera ML, de la Guardia M, Chaudhuri K (2002) Altered elemental profile as indicator of homeostatic imbalance in pathogenesis of oral submucous fibrosis. Biol Trace Elem Res 87(1–3):45–56
Ray JG, Ghosh R, Mallick D, Swain N, Gandhi P, Ram SS et al (2011) Correlation of trace elemental profiles in blood samples of Indian patients with leukoplakia and oral submucous fibrosis. Biol Trace Elem Res 144(1–3):295–305
Doerr TD, Marks SC, Shamsa FH, Mathog RH, Prasad AS (1998) Effects of zinc and nutritional status on clinical outcomes in head and neck cancer. Nutrition 14(6):489–495
Prasad AS, Beck FW, Doerr TD, Shamsa FH, Penny HS, Marks SC et al (1998) Nutritional and zinc status of head and neck cancer patients: an interpretive review. J Am Coll Nutr 17(5):409–418
Abdulla M, Biorklund A, Mathur A, Wallenius K (1979) Zinc and copper levels in whole blood and plasma from patients with squamous cell carcinomas of head and neck. J Surg Oncol 12(2):107–113
Garofalo JA, Erlandson E, Strong EW, Lesser M, Gerold F, Spiro R et al (1980) Serum zinc, serum copper, and the Cu/Zn ratio in patients with epidermoid cancers of the head and neck. J Surg Oncol 15(4):381–386
Mahdavi R, Faramarzi E, Mohammad-Zadeh M, Ghaeammaghami J, Jabbari MV (2007) Consequences of radiotherapy on nutritional status, dietary intake, serum zinc and copper levels in patients with gastrointestinal tract and head and neck cancer. Saudi Med J 28(3):435–440
Gumulec J, Masarik M, Adam V, Eckschlager T, Provaznik I, Kizek R (2014) Serum and tissue zinc in epithelial malignancies: a meta-analysis. PLoS ONE 9(6):e99790
Costello LC, Franklin RB (2011) Zinc is decreased in prostate cancer: an established relationship of prostate cancer! J Biol Inorg Chem 16(1):3–8
Cousins RJ, Liuzzi JP, Lichten LA (2006) Mammalian zinc transport, trafficking, and signals. J Biol Chem 281(34):24085–24089
Finamore A, Roselli M, Merendino N, Nobili F, Vignolini F, Mengheri E (2003) Zinc deficiency suppresses the development of oral tolerance in rats. J Nutr 133(1):191–198
Bao B, Ahmad A, Azmi AS, Wang Z, Banerjee S, Sarkar FH (2012) The Protective Role of Zinc inCancer: A Potential Chemopreventive Agent. In: Shankar S, Srivastava R (eds) Nutrition, Diet and Cancer. Springer, Dordrecht, pp 255–282
Foster M, Samman S (2012) Zinc and regulation of inflammatory cytokines: Implications for cardiometabolic disease. Nutrients 4(7):676–694
Alam MP, Sunardi D, Rinaldi I (2019) Correlation between zinc intake and zinc serum levels with C-reactive protein level in head and neck cancer patients. World Nutri J 2(2):9–14
Callejon-Leblic B, Gomez-Ariza JL, Pereira-Vega A, Garcia-Barrera T (2018) Metal dyshomeostasis based biomarkers of lung cancer using human biofluids. Metallomics 10(10):1444–1451
Diez M, Arroyo M, Cerdan FJ, Munoz M, Martin MA, Balibrea JL (1989) Serum and tissue trace metal levels in lung cancer. Oncology 46(4):230–234
Blockhuys S, Malmberg P, Wittung-Stafshede P (2018) Copper distribution in breast cancer cells detected by time-of-flight secondary ion mass spectrometry with delayed extraction methodology. Biointerphases 13(6):06E412
Jayadeep A, Raveendran Pillai K, Kannan S, Nalinakumari KR, Mathew B, Krishnan Nair M et al (1997) Serum levels of copper, zinc, iron and ceruplasmin in oral leukoplakia and squamous cell carcinoma. J Exp Clin Cancer Res 16(3):295–300
Khanna SS, Karjodkar FR (2006) Circulating immune complexes and trace elements (Copper, Iron and Selenium) as markers in oral precancer and cancer: a randomised, controlled clinical trial. Head Face Med 2:33
Marklund SL, Westman NG, Lundgren E, Roos G (1982) Copper- and zinc-containing superoxide dismutase, manganese-containing superoxide dismutase, catalase, and glutathione peroxidase in normal and neoplastic human cell lines and normal human tissues. Cancer Res 42(5):1955–1961
Majumder S, Chatterjee S, Pal S, Biswas J, Efferth T, Choudhuri SK (2009) The role of copper in drug-resistant murine and human tumors. Biometals 22(2):377–384
Balpande AR, Sathawane RS (2010) Estimation and comparative evaluation of serum iron, copper, zinc and copper/zinc Ratio in oral leukoplakia, submucous fibrosis and squamous cell carcinoma. J Indian Acad Oral Med Radiol 22(2):73–76
Lavilla I, Costas M, Miguel PS, Millos J, Bendicho C (2009) Elemental fingerprinting of tumorous and adjacent non-tumorous tissues from patients with colorectal cancer using ICP-MS. ICP-OES and chemometric analysis Biometals 22(6):863–875
Yoshida D, Ikeda Y, Nakazawa S (1993) Quantitative analysis of copper, zinc and copper/zinc ratio in selected human brain tumors. J Neurooncol 16(2):109–115
Ford ES (2000) Serum copper concentration and coronary heart disease among US adults. Am J Epidemiol 151(12):1182–1188
Theophanides T, Anastassopoulou J (2002) Copper and carcinogenesis. Crit Rev Oncol Hematol 42(1):57–64
Huang YL, Sheu JY, Lin TH (1999) Association between oxidative stress and changes of trace elements in patients with breast cancer. Clin Biochem 32(2):131–136
Ayinampudi BK, Narsimhan M (2012) Salivary copper and zinc levels in oral pre-malignant and malignant lesions. J Oral Maxillofac Pathol 16(2):178–182
Guo CH, Chen PC, Yeh MS, Hsiung DY, Wang CL (2011) Cu/Zn ratios are associated with nutritional status, oxidative stress, inflammation, and immune abnormalities in patients on peritoneal dialysis. Clin Biochem 44(4):275–280
Mezzetti A, Pierdomenico SD, Costantini F, Romano F, De Cesare D, Cuccurullo F et al (1998) Copper/zinc ratio and systemic oxidant load: effect of aging and aging-related degenerative diseases. Free Radic Biol Med 25(6):676–681
Yucel I, Arpaci F, Ozet A, Doner B, Karayilanoglu T, Sayar A et al (1994) Serum copper and zinc levels and copper/zinc ratio in patients with breast cancer. Biol Trace Elem Res 40(1):31–38
Zowczak M, Iskra M, Torlinski L, Cofta S (2001) Analysis of serum copper and zinc concentrations in cancer patients. Biol Trace Elem Res 82(1–3):1–8
Juloski JT, Rakic A, Cuk VV, Cuk VM, Stefanovic S, Nikolic D et al (2020) Colorectal cancer and trace elements alteration. J Trace Elem Med Biol 59:126451
Fabris C, Farini R, Del Favero G, Gurrieri G, Piccoli A, Sturniolo GC et al (1985) Copper, zinc and copper/zinc ratio in chronic pancreatitis and pancreatic cancer. Clin Biochem 18(6):373–375
Khoshdel Z, Naghibalhossaini F, Abdollahi K, Shojaei S, Moradi M, Malekzadeh M (2016) Serum copper and zinc levels among iranian colorectal cancer patients. Biol Trace Elem Res 170(2):294–299
Saleh SAK, Adly HM, Abdelkhaliq AA, Nassir AM (2020) Serum levels of selenium, zinc, copper, manganese, and iron in prostate cancer patients. Curr Urol 14(1):44–49
Ito Y, Suzuki K, Sasaki R, Otani M, Aoki K (2002) Mortality rates from cancer or all causes and SOD activity level and Zn/Cu ratio in peripheral blood: population-based follow-up study. J Epidemiol 12(1):14–21
Bruns F, Mücke R, Büntzel J (2004) Zink und Kupfer. In: Büntzel J, Kisters K, Micke O, Mücke R (eds) Zytoprotektion, Spurenelemente und Elektrolyte in der Tumortherapie. Dustri-Verlag, Munich, pp 120–131
Ho E (2004) Zinc deficiency, DNA damage and cancer risk. J Nutr Biochem 15(10):572–578
Prasad AS, Bao B, Beck FW, Kucuk O, Sarkar FH (2004) Antioxidant effect of zinc in humans. Free Radic Biol Med 37(8):1182–1190
Gaetke LM, Chow CK (2003) Copper toxicity, oxidative stress, and antioxidant nutrients. Toxicology 189(1–2):147–163
Johnson S (2000) The possible role of gradual accumulation of copper, cadmium, lead and iron and gradual depletion of zinc, magnesium, selenium, vitamins B2, B6, D, and E and essential fatty acids in multiple sclerosis. Med Hypotheses 55(3):239–241
Buntzel J, Bruns F, Glatzel M, Garayev A, Mucke R, Kisters K et al (2007) Zinc concentrations in serum during head and neck cancer progression. Anticancer Res 27(4A):1941–1943
Wu T, Sempos CT, Freudenheim JL, Muti P, Smit E (2004) Serum iron, copper and zinc concentrations and risk of cancer mortality in US adults. Ann Epidemiol 14(3):195–201
Acknowledgements
The authors are also grateful to Mr. Anathakrishna, the president of the Mangalore Institute of Oncology for supporting the study.
Funding
The study was supported by Mangalore Institute of Oncology.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they do not have any conflict of interest regarding the study topic.
Ethical Statement
This was a prospective study and was conducted after obtaining clearance from Institutional Ethics Committee (MIO/IEC/07/2017). Written informed consent was taken from all the study participants.
Consent for Publication
All authors consented to the submission of the article for publication
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kudva, A.K., Raghu, S.V., Achar, P.K. et al. Study of Serum Zinc and Copper Levels and Tumor Pathology: A Pilot Study in People Affected with Head and Neck Cancers. Indian J Otolaryngol Head Neck Surg 74 (Suppl 3), 6007–6015 (2022). https://doi.org/10.1007/s12070-021-02589-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12070-021-02589-7